Karyopharm Therapeutics Inc.
3 SEC EDGAR filings indexed (CIK 0001503802) across 1 form type.
Filing profile
Karyopharm Therapeutics Inc. (KPTI) has 3 SEC filings indexed on SecFilingDex, across 1 form type, from September 25, 2026 to October 8, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).
Its most frequent disclosure is the SC 13G/A (5%+ passive stake) with 3 filings — Short-form disclosure of beneficial ownership above 5% by passive investors with no control intent. 3 of these filings were disclosed in the twelve months to October 8, 2026. 3 of the 3 are amendments (a corrected or updated version of an earlier filing).
Disclosure mix
- 3SC 13G/A5%+ passive stake · event-driven
Profile derived from 3 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.
All filings
Authoritative source
SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.
Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.